Cost-Effective Interventions for HIV, Malaria, ...

By Rene Pretorius

April 14, 2025

Limited healthcare budgets demand smart investments. Low- and middle-income countries battle HIV/AIDS, malaria, syphilis, and tuberculosis. A recent
Advancing Early Childhood Health: PureHealth’s Partnership with Abu Dha...
Balancing Pandemic Preparedness Priorities and Military Spending
Reassuring the Private Sector on National Health Insurance South Africa: A Pa...
Exploring the MASLD CKD Socioeconomic Link
Toripalimab Evidence Journey in Cancer Care
Approval of Pembrolizumab Enfortumab Therapy: Insights on Efficacy, Costs, an...
Cancer Control Month 2025: Key Takeaways from President Trump’s National Call...
A Shared-Value Model for Enhancing Diabetes Care in South Africa
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefit...
Prior Authorization Elimination: Is Optum Rx moving towards Access Efficiency?
South Africa Cannabis Regulations: Government Withdraws Ban for New Framework...
Addressing Cancer Care Disparities in Europe: Insights from the 2025 Comparat...